137 related articles for article (PubMed ID: 2623139)
21. Immunohistological studies of the thymus in myasthenia gravis. Correlation with clinical state and thymocyte culture responses.
Thomas JA; Willcox HN; Newsom-Davis J
J Neuroimmunol; 1982 Dec; 3(4):319-35. PubMed ID: 6757263
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the histological and immunohistochemical features of the thymus in young- and elderly-onset myasthenia gravis without thymoma.
Ishii W; Matsuda M; Hanyuda M; Momose M; Nakayama J; Ehara T; Ikeda S
J Clin Neurosci; 2007 Feb; 14(2):110-5. PubMed ID: 17113295
[TBL] [Abstract][Full Text] [Related]
23. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
Lauriola L; Ranelletti F; Maggiano N; Guerriero M; Punzi C; Marsili F; Bartoccioni E; Evoli A
Neurology; 2005 Feb; 64(3):536-8. PubMed ID: 15699390
[TBL] [Abstract][Full Text] [Related]
24. Production of anti-acetylcholine receptor-alpha antibody in vitro by peripheral blood lymphocytes of patients with myasthenia gravis: role of immunoregulatory T cells and monocytes.
Ofosu-Appiah W; Mokhtarian F; Shirazian D; Grob D
J Lab Clin Med; 1994 Aug; 124(2):231-41. PubMed ID: 8051487
[TBL] [Abstract][Full Text] [Related]
25. Myasthenia gravis.
Marx A; Schultz A; Wilisch A; Nenninger R; Müller-Hermelink HK
Verh Dtsch Ges Pathol; 1996; 80():116-26. PubMed ID: 9020569
[TBL] [Abstract][Full Text] [Related]
26. The effects of T cell subpopulations and recombinant interleukin (IL)-2 on peripheral B cell function in patients with myasthenia gravis.
Zhang J; Zhou WB; Wang HL; Guo SS
Hum Antibodies; 1997; 8(2):90-4. PubMed ID: 9289393
[TBL] [Abstract][Full Text] [Related]
27. B- and T-cell activation in the thymus of patients with myasthenia gravis.
Cohen-Kaminsky S; Leprince C; Galanaud P; Richards Y; Berrih-Aknin S
Thymus; 1989; 14(1-3):187-93. PubMed ID: 2623739
[TBL] [Abstract][Full Text] [Related]
28. In vitro anti-acetylcholine receptor antibody synthesis by myasthenia gravis patient lymphocytes: correlations with thymic histology and thymic epithelial-cell interactions.
Safar D; Berrih-Aknin S; Morel E
J Clin Immunol; 1987 May; 7(3):225-34. PubMed ID: 3496354
[TBL] [Abstract][Full Text] [Related]
29. Thymic Germinal Centers and Corticosteroids in Myasthenia Gravis: an Immunopathological Study in 1035 Cases and a Critical Review.
Truffault F; de Montpreville V; Eymard B; Sharshar T; Le Panse R; Berrih-Aknin S
Clin Rev Allergy Immunol; 2017 Feb; 52(1):108-124. PubMed ID: 27273086
[TBL] [Abstract][Full Text] [Related]
30. Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG.
Leite MI; Ströbel P; Jones M; Micklem K; Moritz R; Gold R; Niks EH; Berrih-Aknin S; Scaravilli F; Canelhas A; Marx A; Newsom-Davis J; Willcox N; Vincent A
Ann Neurol; 2005 Mar; 57(3):444-8. PubMed ID: 15732104
[TBL] [Abstract][Full Text] [Related]
31. Acetylcholine receptors in human thymic myoid cells in situ: an immunohistological study.
Schluep M; Willcox N; Vincent A; Dhoot GK; Newsom-Davis J
Ann Neurol; 1987 Aug; 22(2):212-22. PubMed ID: 3662452
[TBL] [Abstract][Full Text] [Related]
32. Altered intrathymic T-cell repertoire in human myasthenia gravis.
Truffault F; Cohen-Kaminsky S; Khalil I; Levasseur P; Berrih-Aknin S
Ann Neurol; 1997 Jun; 41(6):731-41. PubMed ID: 9189034
[TBL] [Abstract][Full Text] [Related]
33. Regulatory and pathogenic mechanisms in human autoimmune myasthenia gravis.
Le Panse R; Cizeron-Clairac G; Cuvelier M; Truffault F; Bismuth J; Nancy P; De Rosbo NK; Berrih-Aknin S
Ann N Y Acad Sci; 2008; 1132():135-42. PubMed ID: 18567863
[TBL] [Abstract][Full Text] [Related]
34. Acetylcholine receptor autoantibody secretion by thymocytes: relationship to myasthenia gravis.
Yoshikawa H; Lennon VA
Neurology; 1997 Aug; 49(2):562-7. PubMed ID: 9270597
[TBL] [Abstract][Full Text] [Related]
35. Myasthenia gravis thymus: clinical, histological and culture correlations.
Schluep M; Willcox N; Ritter MA; Newsom-Davis J; Larché M; Brown AN
J Autoimmun; 1988 Oct; 1(5):445-67. PubMed ID: 3254184
[TBL] [Abstract][Full Text] [Related]
36. Double labelled T suppressor lymphocytes in the thymus of a patient with myasthenia gravis: morphological and immunological characteristics.
Bárdosi L; Ambrus M; Koltay M; Karlinger GT; Gellért M
J Clin Lab Immunol; 1982 Jan; 7(1):75-80. PubMed ID: 6461769
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of Bcl-2 protein in the myasthenic thymus.
Onodera J; Nakamura S; Nagano I; tobita M; Yoshioka M; Takeda A; Oouchi M; Itoyama Y
Ann Neurol; 1996 Apr; 39(4):521-8. PubMed ID: 8619530
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-6 overproduction by cultured thymic epithelial cells from patients with myasthenia gravis is potentially involved in thymic hyperplasia.
Cohen-Kaminsky S; Devergne O; Delattre RM; Klingel-Schmitt I; Emilie D; Galanaud P; Berrih-Aknin S
Eur Cytokine Netw; 1993; 4(2):121-32. PubMed ID: 8318672
[TBL] [Abstract][Full Text] [Related]
39. Responses in vitro of peripheral blood lymphocytes from patients with myasthenia gravis to stimulation with human acetylcholine receptor alpha-chain peptides: analysis in relation to age, thymic abnormality, and ethnicity.
Oshima M; Deitiker PR; Mosier DR; Smith RG; Atassi MZ
Hum Immunol; 2005 Jan; 66(1):32-42. PubMed ID: 15620460
[TBL] [Abstract][Full Text] [Related]
40. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
